Retinal gene therapy coming of age

Human Gene Therapy

Volumn 24, Issue 3, 2013, Pages 242-244

  Cepko, Connie L ^a   Vandenberghe, Luk H ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

AUTOSOMAL RECESSIVE INHERITANCE; CELL SPECIFICITY; DISEASE COURSE; EXPERIMENTAL DOG; EXPERIMENTAL THERAPY; FOLLOW UP; GENE THERAPY; HISTORY; HUMAN; IN VIVO STUDY; LEBER CONGENITAL AMAUROSIS; LONG TERM CARE; NONHUMAN; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR CELL; RETINA DEGENERATION; RETINA DYSTROPHY; WILD TYPE;

EID: 84875454136     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.050     Document Type: Note

References (13)

1. Bainbridge, J.W., Smith, A.J., Barker, S.S., et al. (2008). Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358, 2231-2239.
2. Bramall, A.N., Wright, A.F., Jacobson, S.G., and McInnes, R.R. (2010). The genomic, biochemical, and cellular responses of the retina in inherited photoreceptor degenerations and prospects for the treatment of these disorders. Annu. Rev. Neurosci. 33, 441-472.
3. Cideciyan, A.V., Aleman, T.S., Boye, S.L., et al. (2008). Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U. S. A. 105, 15112-15117.
4. Cideciyan, A.V., Jacobson, S.G., Beltran, W.A., et al. (2013). Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc. Natl. Acad. Sci. U. S. A. 110, E517-525.
5. Hartong, D.T., Berson, E.L., and Dryja, T.P. (2006). Retinitis pigmentosa. Lancet 368, 1795-1809.
6. Hauswirth, W.W., Aleman, T.S., Kaushal, S., et al. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum. Gene Ther. 19, 979-990.
7. Huang, P.C., Gaitan, A.E., Hao, Y., et al. (1993). Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc. Natl. Acad. Sci. U. S. A. 90, 8484-8488.
8. Kedzierski, W., Bok, D., and Travis, G.H. (1998). Non-cell-autonomous photoreceptor degeneration in rds mutant mice mosaic for expression of a rescue transgene. J. Neurosci. 18, 4076-4082.
9. Maguire, A.M., Simonelli, F., Pierce, E.A., et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240-2248.
10. Maguire, A.M., High, K.A., Auricchio, A., et al. (2009). Agedependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 374, 1597-1605.
11. Punzo, C., Xiong, W., and Cepko, C.L. (2012). Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame? J. Biol. Chem. 287, 1642-1648.
12. Sieving, P.A., Caruso, R.C., Tao, W., et al. (2006). Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of Cntf delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. U. S. A. 103, 3896-3901.
13. Vandenberghe, L.H., and Auricchio, A. (2012). Novel adenoassociated viral vectors for retinal gene therapy. Gene Ther. 19, 162-168.